MedTrace Logo

Effects of Sufentanil Target Controlled Infusion on Patient State Index Values and Electroencephalographic Spectrum During Total Intravenous Anesthesia With Propofol

NCT06388408 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2024-10-24

No results posted yet for this study

Summary

Sufentanil Target Controlled infusion (TCI, Gepts model) effects on Neuromonitoring during Total Intravenous Anesthesia (TIVA) with Propofol TCI (Eleveld model) has not been investigate yet.

Authors aim to investigate its effect on Patient State index (PSi), the power spectrum EEG, the Analgesia Nociception Index (ANI) nad pupillometry values during maintenance durin TIVA-TCI with Propofol and Sufentanil.

Conditions

  • Anesthesia Brain Monitor
  • Sufentanil
  • Target Controlled Infusion

Sponsors & Collaborators

  • University of Padova

    lead OTHER

Principal Investigators

  • Federico Linassi, MD · University of Padova

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-05
Primary Completion
2024-09-15
Completion
2024-09-30

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06388408 on ClinicalTrials.gov